These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade. Alessandrini M; Chaudhry M; Dodgen TM; Pepper MS OMICS; 2016 Oct; 20(10):593-603. PubMed ID: 27643672 [TBL] [Abstract][Full Text] [Related]
4. Antidepressant prescribing in the precision medicine era: a prescriber's primer on pharmacogenetic tools. Bousman CA; Forbes M; Jayaram M; Eyre H; Reynolds CF; Berk M; Hopwood M; Ng C BMC Psychiatry; 2017 Feb; 17(1):60. PubMed ID: 28178974 [TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics for personalized pain medicine. Ko TM; Wong CS; Wu JY; Chen YT Acta Anaesthesiol Taiwan; 2016 Mar; 54(1):24-30. PubMed ID: 26976339 [TBL] [Abstract][Full Text] [Related]
6. Genetics and personalized medicine in antidepressant treatment. Gvozdic K; Brandl EJ; Taylor DL; Müller DJ Curr Pharm Des; 2012; 18(36):5853-78. PubMed ID: 22681166 [TBL] [Abstract][Full Text] [Related]
7. Genome-wide association studies in pharmacogenomics of antidepressants. Lin E; Lane HY Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525 [TBL] [Abstract][Full Text] [Related]
8. From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment. Fabbri C; Porcelli S; Serretti A Can J Psychiatry; 2014 Feb; 59(2):62-75. PubMed ID: 24881125 [TBL] [Abstract][Full Text] [Related]
10. Antidepressants for people with epilepsy and depression. Maguire MJ; Marson AG; Nevitt SJ Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531 [TBL] [Abstract][Full Text] [Related]
11. Which can Predict the Outcome of Antidepressants: Metabolic Genes or Pharmacodynamic Genes? Zheng N; Niu M; Zang Y; Zhuang H; Jia F; Bao S; Liu S Curr Drug Metab; 2023; 24(7):525-535. PubMed ID: 37691197 [TBL] [Abstract][Full Text] [Related]
12. Antidepressant pharmacogenetics in children and young adults: A systematic review. Maruf AA; Greenslade A; Arnold PD; Bousman C J Affect Disord; 2019 Jul; 254():98-108. PubMed ID: 31112844 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression. Islam F; Gorbovskaya I; Müller DJ Adv Exp Med Biol; 2021; 1305():231-255. PubMed ID: 33834403 [TBL] [Abstract][Full Text] [Related]
14. Progress and prospects in pharmacogenetics of antidepressant drugs. Fabbri C; Crisafulli C; Calabrò M; Spina E; Serretti A Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1157-68. PubMed ID: 27310483 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic guidelines and decision support tools for depression treatment: application to late-life. Chang DD; Eyreeuro HA; Abbott R; Coudreaut M; Baune BT; Shaman JA; Lavretsky H; Lenze EJ; Merrill DA; Singh AB; Mulsant BH; Reynolds CF; Müller DJ; Bousman C Pharmacogenomics; 2018 Nov; 19(16):1269-1284. PubMed ID: 30422065 [TBL] [Abstract][Full Text] [Related]
16. The role of pharmacogenetics in the treatment of depression and anxiety disorders. Schosser A; Kasper S Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481 [TBL] [Abstract][Full Text] [Related]
17. Antidepressants for people with epilepsy and depression. Maguire MJ; Weston J; Singh J; Marson AG Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360 [TBL] [Abstract][Full Text] [Related]